We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Axos Financial
AX
$5.45B
| – | – |
-71,195
| Closed | -$2.55M |
|
|
DCH
3302
Dauch Corp
DCH
$1.32B
| – | – |
-52,911
| Closed | -$398K |
|
3303
AXT Inc
AXTI
$3.13B
| – | – |
-66,482
| Closed | -$390K |
|
3304
Axsome Therapeutics
AXSM
$12.3B
| – | – |
-27,393
| Closed | -$1.05M |
|
3305
Azenta
AZTA
$1.27B
| – | – |
-453,107
| Closed | -$32.7M |
|
3306
Boeing
BA
$167B
| – | – |
-418,362
| Closed | -$57.2M |
|
3307
Braskem
BAK
$972M
| – | – |
-82,528
| Closed | -$1.18M |
|
3308
Bally's
BALY
$686M
| – | – |
-22,534
| Closed | -$448K |
|
3309
Banner Corp
BANR
$2.39B
| – | – |
-12,160
| Closed | -$684K |
|
3310
Credicorp
BAP
$31.1B
| – | – |
-1,672
| Closed | -$201K |
|
3311
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.3B
| – | – |
-3,788
| Closed | -$334K |
|
3312
BioAtla
BCAB
$5.64M
| – | – |
-1,091
| Closed | -$156K |
|
3313
Banco de Chile
BCH
$20.9B
| – | – |
-108,607
| Closed | -$1.98M |
|
3314
Brink's
BCO
$4.86B
| – | – |
-17,168
| Closed | -$1.04M |
|
3315
BioCryst Pharmaceuticals
BCRX
$2.43B
| – | – |
-35,574
| Closed | -$376K |
|
|
BELFB
3316
Bel Fuse Inc Class B
BELFB
$3.84B
| – | – |
-53,096
| Closed | -$826K |
|
3317
Franklin Resources
BEN
$17.3B
| – | – |
-228,498
| Closed | -$5.33M |
|
3318
Brookfield Renewable
BEPC
$5.95B
| – | – |
-134,313
| Closed | -$4.78M |
|
3319
Bunge Global
BG
$22.8B
| – | – |
-211,325
| Closed | -$19.2M |
|
3320
Brookfield Infrastructure
BIPC
$5.03B
| – | – |
-9,293
| Closed | -$395K |
|
3321
Bakkt Inc
BKKT
$338M
| – | – |
-2,494
| Closed | -$131K |
|
3322
PUT
Booking.com
BKNG
$145B
| – | – |
-262,500
| Closed | -$18.4M |
|
3323
Baker Hughes
BKR
$60.1B
| – | – |
-96,837
| Closed | -$2.79M |
|
3324
Blend Labs
BLND
$424M
| – | – |
-839,847
| Closed | -$1.98M |
|
3325
Blink Charging
BLNK
$79.5M
| – | – |
-24,964
| Closed | -$414K |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.